Catalysts for Merz Pharmaceuticals LLC
29 tracked
Mar 31, 2026
approval
INBRIJA (LEVODOPA) — FDA approval
levodopa
→
Mar 20, 2026
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Feb 26, 2026
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Dec 17, 2025
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Jul 5, 2024
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Sep 8, 2023
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Aug 13, 2021
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Apr 19, 2021
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Apr 19, 2021
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Apr 19, 2021
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Apr 19, 2021
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Apr 19, 2021
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Dec 18, 2020
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Dec 18, 2020
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Aug 31, 2020
approval
INBRIJA (LEVODOPA) — FDA approval
levodopa
→
Aug 31, 2020
approval
INBRIJA (LEVODOPA) — FDA approval
levodopa
→
Aug 18, 2020
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Aug 29, 2019
approval
INBRIJA (LEVODOPA) — FDA approval
levodopa
→
May 10, 2019
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Dec 21, 2018
approval
INBRIJA (LEVODOPA) — FDA approval
levodopa
→
Jul 3, 2018
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Dec 22, 2015
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Nov 20, 2015
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Apr 11, 2013
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Jul 16, 2012
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Jul 20, 2011
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Jun 2, 2011
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Jul 30, 2010
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→
Jul 30, 2010
approval
Xeomin (incobotulinumtoxinA) — FDA approval
Merz Pharmaceuticals LLC
→